Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02679885 · ClinicalTrials.gov registry record
Teriflunomide Male Transmission Study
A clinical trial, sponsored by Griffin Hospital.
- Completed
- Registry status
- 20
- Enrollment target
NCT02679885 is a clinical trial that has completed, run by Griffin Hospital. The registered enrollment target is 20 participants.
The verdict
NCT02679885 has completed, sponsored by Griffin Hospital.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
It is known that teriflunomide, a treatment for relapsing forms of multiple sclerosis, can be found in low concentrations in semen. Because the drug has been associated with teratogenicity in laboratory animals, the question is raised as to whether the drug can be detected in female partners of sexually active males who are taking the drug to treat their multiple sclerosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-10 |
| Est. Completion | 2018-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02679885
The ClinicalTrials.gov registry entry for NCT02679885 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Griffin Hospital, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02679885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02679885 about?
NCT02679885 is a clinical study titled "Teriflunomide Male Transmission Study". It is known that teriflunomide, a treatment for relapsing forms of multiple sclerosis, can be found in low concentrations in semen. Because the drug has been associated with teratogenicity in laboratory animals, the question is raised as to whether the drug can be detected in female partners of sexu...
What is the current status of trial NCT02679885?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2015-10. Estimated completion is 2018-09.
Who is sponsoring clinical trial NCT02679885?
This trial is sponsored by Griffin Hospital, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.